Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
Healthy Volunteers
NCT05370287

Adaptive Optics Retinal Imaging

Led by Food and Drug Administration (FDA) · Updated on 2026-05-08

150

Participants Needed

1

Research Sites

557 weeks

Total Duration

On this page

Sponsors

F

Food and Drug Administration (FDA)

Lead Sponsor

U

University of Maryland, Baltimore

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.

CONDITIONS

Official Title

Adaptive Optics Retinal Imaging

Who Can Participate

Age: 21Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Are 21 years of age or older
  • Can cooperate with instructions during adaptive optics imaging
  • Can understand and sign informed consent
  • Diagnosed with primary open angle glaucoma (for cohort 2)
Not Eligible

You will not qualify if you...

  • Are under 21 years of age
  • Have conditions preventing adequate imaging (e.g., unstable fixation, media opacity)
  • Have visual correction outside +4 to -8 diopters
  • Have history of adverse reaction to mydriatic drops
  • Have narrow iridocorneal angle or history of acute angle closure glaucoma
  • Do not meet criteria for primary open angle glaucoma per American Academy of Ophthalmology (cohort 2)
  • Have health conditions contraindicating oxygen supplementation (e.g., COPD, emphysema, asthma, obstructive or restrictive lung disease) (RBF experiment only)
  • Depend on oxygen support or have baseline oxygen saturation below 95% (RBF experiment only)
  • Tested positive for COVID-19 at enrollment or have acute/chronic photophobia
  • Are working under direct supervision of Dr. Hammer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Food and Drug Administration

Silver Spring, Maryland, United States, 20993

Actively Recruiting

Loading map...

Research Team

D

Daniel X Hammer, Ph.D.

CONTACT

Z

Zhuolin Liu, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Adaptive Optics Retinal Imaging | DecenTrialz